Education And Debate
Updated New Zealand cardiovascular disease risk-benefit prediction guide
BMJ 2000; 320 doi: https://doi.org/10.1136/bmj.320.7236.709 (Published 11 March 2000) Cite this as: BMJ 2000;320:709
Related articles
- Editorial Published: 11 March 2000; BMJ 320 doi:10.1136/bmj.320.7236.659
- Clinical Review Published: 05 January 2009; BMJ 338 doi:10.1136/bmj.a2844
- Correction Published: 09 December 2000; BMJ 321 doi:
See more
- Why are UK cardiovascular deaths in under 65s rising again?BMJ May 19, 2025, 389 r1015; DOI: https://doi.org/10.1136/bmj.r1015
- Prescribing parkrun: medicalising a walk in the parkBMJ April 08, 2025, 389 r670; DOI: https://doi.org/10.1136/bmj.r670
- GPs can prescribe tirzepatide to priority patient groups from JuneBMJ April 02, 2025, 389 r665; DOI: https://doi.org/10.1136/bmj.r665
- Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reportsBMJ February 12, 2025, 388 r287; DOI: https://doi.org/10.1136/bmj.r287
- Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog findsBMJ November 13, 2024, 387 q2518; DOI: https://doi.org/10.1136/bmj.q2518
Cited by...
- GPs familiarity with and use of cardiovascular clinical prediction rules: a UK survey study
- Cardiovascular disease risk perception in a Hungarian community sample: psychometric evaluation of the ABCD Risk Perception Questionnaire
- Association Between Work-Related Stress and Coronary Heart Disease: A Review of Prospective Studies Through the Job Strain, Effort-Reward Balance, and Organizational Justice Models
- Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention
- Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review
- Application of two versions of the WHO/international society of hypertension absolute cardiovascular risk assessment tools in a rural Bangladeshi population
- Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels
- Clinical prediction rules in practice: review of clinical guidelines and survey of GPs
- Polypill Therapy, Subclinical Atherosclerosis, and Cardiovascular Events--Implications for the Use of Preventive Pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis)
- Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results)
- Inclusion of Stroke as an Outcome and Risk Equivalent in Risk Scores for Primary and Secondary Prevention of Vascular Disease
- 'Your Heart Forecast': a new approach for describing and communicating cardiovascular risk?
- Cardiovascular Risk Prediction: Basic Concepts, Current Status, and Future Directions
- Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial
- Risk assessment in asthma and COPD: a potential role for biomarkers?
- Evaluating cardiovascular risk assessment for asymptomatic people
- Biomarkers in the assessment and management of airways diseases
- General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
- The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency
- Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review
- Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk
- Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
- Doxazosin versus bendrofluazide: a comparison of the metabolic effects in British South Asians with hypertension
- A Risk Prediction Tool for Melanoma?
- Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study
- From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part II
- An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas
- Controlled trial of effect of documented cardiovascular risk scores on prescribing
- Application of Framingham risk estimates to ethnic minorities in United Kingdom and implications for primary prevention of heart disease in general practice: cross sectional population based study
- The 2001 Canadian hypertension recommendations: take-home messages
- Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?
- Screening for cardiovascular risk: public health imperative or matter for individual informed choice?
- Absolute, attributable, and relative risk in the management of coronary heart disease
- Comparative accuracy of cardiovascular risk prediction methods in primary care patients
- Guidelines on preventing cardiovascular disease in clinical practice